PropertyValue
?:abstract
  • [Image: see text] The outbreak of SARS-CoV-2 is posing serious global public health problems. Facing the emergence of this pandemic, we established a portable microfluidic immunoassay system for easy-to-use, sensitive, rapid (<15 min), multiple, and on-site detection of IgG/IgM/Antigen of SARS-CoV-2 simultaneously. This integrated method was successfully applied for detecting SARS-CoV-2 IgM and IgG antibodies in clinical human serum as well as SARS-CoV-2 antigen in pharyngeal swabs from 26 patients with COVID-19 infection and 28 uninfected people. The assay demonstrated high sensitivity and specificity, which is promising for the diagnosis and monitoring as well as control of SARS-CoV-2 worldwide.
?:creator
?:doi
?:doi
  • 10.1021/acs.analchem.0c01635
?:journal
  • Anal_Chem
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/1919de868815b4ae66d5c31f0483051222424571.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7351017.xml.json
?:pmcid
?:pmid
?:pmid
  • 32615038.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min
?:type
?:year
  • 2020-07-02

Metadata

Anon_0  
expand all